Ebusco is trading at €0.17, down 6.64%, with no specific October 13 catalyst identified.
- Ebusco’s latest disclosed update, dated October 9, said Gotion approved €5.86 million for Rouen production, but the funds do not cover operating expenses.
- Ebusco warned it needed significant short-term funding and that liquidity covered only a short period; a direct link to the October 13 decline is unconfirmed.
- U.S. indexes in the supplied market context were down less than 0.5%, not establishing a significant same-direction driver.